| 2022 | | A Machine Learning Approach Using PET/CT-based Radiomics for Prediction of PD-L1 Expression in Non-small Cell Lung Cancer | 고영화, 이수진 |
| 2016 | | A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806) | 강석윤, 최진혁 |
| 2024 | | A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR Mutations | 이현우 |
| 2016 | | Aldehyde dehydrogenase is used by cancer cells for energy metabolism | 이재호 |
| 2023 | | An integrated single-cell transcriptomic dataset for non-small cell lung cancer | 임수빈 |
| 2022 | | Analysis of thromboembolic events in patients with non-small cell lung cancer who received adjuvant chemotherapy: single-center real-world data | 강석윤, 김태환, 신승수, 안미선, 이현우, 최용원, 최진혁 |
| 2008 | | Are there any ethnic differences in molecular predictors of erlotinib efficacy in advanced non-small cell lung cancer? | 최진혁 |
| 2022 | | Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer | 김석휘 |
| 2022 | | Artificial intelligence–powered programmed death ligand 1 analyser reduces interobserver variation in tumour proportion score for non–small cell lung cancer with better prediction of immunotherapy response | 김석휘 |
| 2022 | | Assessment of textbook outcome after lobectomy for early-stage non-small cell lung cancer in a Korean institution: A retrospective study | 유우식, 정준호, 함석진 |
| 2019 | | Association between 18F-FDG uptake in PET/CT, Nrf2, and NQO1 expression and their prognostic significance in non-small cell lung cancer | 고영화, 이수진, 한재호 |
| 2018 | | Associations Between PET Textural Features and GLUT1 Expression, and the Prognostic Significance of Textural Features in Lung Adenocarcinoma | 고영화, 이수진 |
| 2002 | | Bilateral adrenal metastases revealed by F-18 FDG coincidence detection positron emission tomography in a patient with lung cancer. | 박찬희, 오윤정 |
| 2009 | | Clinical usefulness of the fluorodeoxyglucose (FDG)-PET maximal standardized uptake value (SUV) in combination with CT features for the differentiation of adenocarcinoma with a bronchioloalveolar carcinoma from other subtypes of non-small cell lung cancers. | 박경주, 선주성, 신승수, 윤준기, 이기범, 황성철 |
| 2024 | | Clinical Validation of Artificial Intelligence-Powered PD-L1 Tumor Proportion Score Interpretation for Immune Checkpoint Inhibitor Response Prediction in Non-Small Cell Lung Cancer | 김석휘 |
| 1997 | | Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma. | 이이형 |
| 2024 | | Deep learning–radiomics integrated noninvasive detection of epidermal growth factor receptor mutations in non-small cell lung cancer patients | 김철호, 노진, 유슬기, 허재성 |
| 2020 | | DeepBTS: Prediction of Recurrence-free Survival of Non-small Cell Lung Cancer Using a Time-binned Deep Neural Network | 이현우 |
| 2008 | | Diagnostic performance of (18)F-FDG PET/CT for lymph node staging in patients with operable non-small-cell lung cancer and inflammatory lung disease. | 박경주, 박광주, 선주성, 신승수, 윤준기, 이기범, 이성수, 황성철 |
| 2024 | | Differential efficacy of tyrosine kinase inhibitors according to the types of EGFR mutations and agents in non-small cell lung cancer: a real-world study | 강석윤, 고영화, 김태환, 신승수, 안미선, 이현우, 최용원, 최진혁 |
| 2017 | | Differential expression and prognostic significance of GLUT1 according to histologic type of non-small-cell lung cancer and its association with volume-dependent parameters | 고영화, 박성용, 이수진 |
| 2017 | | Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer? | 최용원, 최진혁 |
| 2019 | | Dummy Run of Quality Assurance Program before Prospective Study of Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases from Non-small Cell Lung Cancer: Korean Radiation Oncology Group (KROG) 17-06 Study | 노오규 |
| 2017 | | Effect of formalin fixation and tumour size in small-sized non-small-cell lung cancer: a prospective, single-centre study | 함석진 |
| 2018 | | EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients | 강석윤, 고영화, 박준성, 신승수, 이현우, 정성현, 최용원, 최진혁, 한재호 |
| 2010 | | Emphysema as a risk factor for the outcome of surgical resection of lung cancer. | 박경주, 박광주, 박주헌, 선주성, 신승수, 이규성, 이성수, 정우영, 최호, 황성철 |
| 2009 | | Erlotinib monotherapy for stage IIIB/IV non-small cell lung cancer: a multicenter trial by the Korean Cancer Study Group. | 최진혁 |
| 2018 | | ESE1 suppresses the growth, invasion and migration of human NSCLC cells and tumor formation in vivo | 김철호, 이복순 |
| 2009 | | Expression of excision repair cross-complementation group 1 protein predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based doublet chemotherapy. | 강석윤, 김장희, 박광주, 신승수, 오영택, 이현우, 정성현, 정재호, 최진혁, 한재호, 황성철 |
| 2021 | | Expression of PD-L1, cancer stem cell and epithelial–mesenchymal transition phenotype in non-small cell lung cancer | 고영화, 한재호, 함석진 |
| 2025 | | F-18 FDG PET-derived imaging biomarkers of airway inflammation and their clinical associations in patients with non-small cell lung cancer | 박용진, 이수진 |
| 2005 | | False negative F-18 FDG PET/CT in nonsmall cell lung cancer bone metastases. | 윤석남, 윤준기, 조철우 |
| 2019 | | Interferon-induced transmembrane protein 1-mediated EGFR/SOX2 signaling axis is essential for progression of non-small cell lung cancer | 고영화 |
| 2021 | | Interferon-γ-inducible chemokines as prognostic markers for lung cancer | 박광주, 박주헌, 박지은, 신승수, 이규성, 정우영, 정윤정 |
| 2015 | | Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer? | 강석윤, 박준성, 안미선, 이순영, 이현우, 정성현, 최용원, 최진혁 |
| 2024 | | Lazertinib versus Gefitinib as First-Line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset | 최진혁 |
| 2022 | | Longitudinal monitoring by next-generation sequencing of plasma cell-free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors | 권민석 |
| 2008 | | Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histology. | 강석윤, 김장희, 박광주, 신승수, 오영택, 이현우, 정성현, 최진혁, 최호, 한재호, 황성철 |
| 2015 | | Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04. | 최진혁 |
| 2007 | | Neutrophilic eccrine hidradenitis in non-small cell lung cancer. | 김유찬 |
| 2020 | | Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09) | 안미선 |
| 2019 | | PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data | 고영화, 이수진, 이현우, 정준호, 한재호, 함석진 |
| 2007 | | Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer. | - |
| 2007 | | Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5. | 장영주 |
| 2015 | | Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer. | 박광주, 박성용, 윤준기, 이수진 |
| 2017 | | Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy | 고영화, 이현우 |
| 2014 | | Prognostic implication of pulmonary function at the beginning of postoperative radiotherapy in non-small cell lung cancer | 노오규, 오영택 |
| 2017 | | Prognostic significance of lactate dehydrogenase B according to histologic type of non-small-cell lung cancer and its association with serum lactate dehydrogenase | 고영화, 이수진 |
| 2023 | | Prognostic value of pretherapeutic FDG PET/CT in non-small cell lung cancer with pulmonary lymphangitic carcinomatosis | 박용진 |
| 2015 | | Prognostic value of total lesion glycolysis by 18F-FDG PET/CT in surgically resected stage IA non-small cell lung cancer. | 박성용 |
| 2016 | | Radiation Therapy-First Strategy After Surgery With or Without Adjuvant Chemotherapy in Stage IIIA-N2 Non-Small Cell Lung Cancer | 노오규, 박래웅, 박성용, 안미선, 오영택, 윤덕용, 이현우, 전미선, 최진혁, 허재성 |
